BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34239322)

  • 1. Clinical Outcome of Acquired Post-Immunosuppressive-Therapy Aplastic Anemia in Pediatric Patients: A 13-Year Experience in Two Southern China Tertiary Care Centers.
    Huang J; Huang L; Liu S; Lin S; Cheng Y; Jiang X; Xue H; Li C; Chen C
    Int J Gen Med; 2021; 14():3133-3144. PubMed ID: 34239322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relapse and clonal disease in children with aplastic anemia (AA) after immunosuppressive therapy (IST): the SAA 94 experience. German/Austrian Pediatric Aplastic Anemia Working Group.
    Führer M; Burdach S; Ebell W; Gadner H; Haas R; Harbott J; Janka-Schaub G; Klingebiel T; Kremens B; Niemeyer C; Rampf U; Reiter A; Ritter J; Schulz A; Walther U; Zeidler C; Bender-Götze C
    Klin Padiatr; 1998; 210(4):173-9. PubMed ID: 9743949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The Efficacy and Influencing Factors of Cyclosporine Alone in the Treatment of Children with Acquired Aplastic Anemia].
    Qin HC; Guan XM; Hu YN; Lei XY; Dou Y; Yu J; Wen XH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Jun; 32(3):841-846. PubMed ID: 38926977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response To Immunosuppressive Therapy In Patients Of Acquired Aplastic Anaemia: A Single Center Experience From A Developing Country.
    Khan M; Iftikhar R; Chaudhry QU; Mehmood SK; Faraz T; Ghafoor T; Shahbaz N; Khan MA; Shamshad GU; Khattak TA
    J Ayub Med Coll Abbottabad; 2022; 34(Suppl 1)(4):S969-S973. PubMed ID: 36550655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The life span of red blood cell in patients with severe/very severe aplastic anemia].
    Ye L; Guo J; Jing LP; Peng GX; Zhou K; Li Y; Li Y; Li JP; Fan HH; Song L; Zhang FK; Zhang L
    Zhonghua Xue Ye Xue Za Zhi; 2018 Feb; 39(2):137-142. PubMed ID: 29562449
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects and Predictive Factors of Immunosuppressive Therapy Combined with Umbilical Cord Blood Infusion in Patients with Severe Aplastic Anemia.
    Zhang X; Li Z; Geng W; Song B; Wan C
    Yonsei Med J; 2018 Jul; 59(5):643-651. PubMed ID: 29869462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of combined immunosuppressive therapy plus umbilical cord blood infusion in severe aplastic anemia patients: A cohort study.
    Luo X; Lu H; Xiu B; Wu H; Li B; Li P; Chen Y; Zhou L; Zhang W; Dong Y; Liang A; Ding Y
    Exp Ther Med; 2018 Feb; 15(2):1966-1974. PubMed ID: 29434791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein-A is a potential prognostic biomarker for severe aplastic anemia patients treated with ATG-based immunosuppressive therapy: a single-center retrospective study.
    Liu Q; Dong H; Li Y; Shen Y; Hong Y; Chen Y; Liu S; Wu X; Liu W; Hu H; Zhao Y; Lin S; Shen Y; Zhou Y; Ye B; Wu D
    Lipids Health Dis; 2022 Oct; 21(1):93. PubMed ID: 36192750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adult aplastic anemia in Thailand: incidence and treatment outcome from a prospective nationwide population-based study.
    Norasetthada L; Wongkhantee S; Chaipokam J; Charoenprasert K; Chuncharunee S; Rojnuckarin P; Sirijerachai C; Wanachiwanawin W; Issaragrisil S;
    Ann Hematol; 2021 Oct; 100(10):2443-2452. PubMed ID: 34269837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profile and Predictors of Infection Following Anti-thymocyte Globulin or Anti-lymphocyte Globulin with Cyclosporine in Aplastic Anemia.
    Lionel SA; Selvarajan S; Korula A; Kulkarni U; Devasia A; Abubacker FN; Abraham A; Mathews V; Lakshmi KM; George B
    Indian J Hematol Blood Transfus; 2023 Jul; 39(3):419-428. PubMed ID: 37304482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes of immunosuppressive therapy for severe aplastic anemia patients with absolute neutrophil count of zero.
    Liu J; Lu XY; Cheng L; Yang Y; Lin SY; Yin H; Liu XQ; Wu XM; He GS
    Hematology; 2019 Dec; 24(1):492-497. PubMed ID: 31221029
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment outcomes of 125 children with aplastic anemia].
    Luo CJ; Chen J; Xue HL; Tang JY; Pan C; Jiang H; Dong L; Luo CY; Ye QD; Zhou M; Gu LJ
    Zhonghua Xue Ye Xue Za Zhi; 2010 Aug; 31(8):531-5. PubMed ID: 21122332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of umbilical cord mesenchymal stem cells and standard immunosuppressive regimen for pediatric patients with severe aplastic anemia.
    Lan Y; Liu F; Chang L; Liu L; Zhang Y; Yi M; Cai Y; Feng J; Han Z; Han Z; Zhu X
    BMC Pediatr; 2021 Feb; 21(1):102. PubMed ID: 33639900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Oxymetholone in Severe and Nonsevere Acquired Aplastic Anemia: A Propensity Score Matching Analysis.
    Pengthina W; Saelue P
    J Blood Med; 2022; 13():753-761. PubMed ID: 36514313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressive therapy with horse anti-thymocyte globulin and cyclosporine as treatment for fulminant aplastic anemia in children.
    Yagasaki H; Shichino H; Ohara A; Kobayashi R; Yabe H; Ohga S; Hamamoto K; Ohtsuka Y; Shimada H; Inoue M; Muramatsu H; Takahashi Y; Kojima S
    Ann Hematol; 2014 May; 93(5):747-52. PubMed ID: 24337487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppressive treatment in children with acquired aplastic anemia.
    Yıldırmak Y; Erdem E; Telhan L; Kepekçi L
    Turk J Haematol; 2012 Jun; 29(2):150-5. PubMed ID: 24744646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural killer cells in peripheral blood at diagnosis predict response to immunosuppressive therapy in severe aplastic anemia.
    Yu W; Wang Q; Ge M; Shi X
    Clin Exp Med; 2023 Sep; 23(5):1815-1822. PubMed ID: 36244022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel therapeutic choices in immune aplastic anemia.
    Scheinberg P
    F1000Res; 2020; 9():. PubMed ID: 32953089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnosis and treatment of aquired aplastic anemia].
    Kulagin AD; Lisukov IA; Kriuchkova IV; Sizikova SA; Gilevich AV; Denisova VV; Filimonov PN; Meniaeva EV; Pronkina NV; Kozhevnikov VS; Chernykh ER; Kozlov VA
    Ter Arkh; 2006; 78(11):48-54. PubMed ID: 17195527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology, Clinico-Haematological Profile and Management of Aplastic Anaemia: AIIMS Experience.
    Mahapatra M; Singh PK; Agarwal M; Prabhu M; Mishra P; Seth T; Tyagi S; Patil HP; Saxena R
    J Assoc Physicians India; 2015 Mar; 63(3 Suppl):30-5. PubMed ID: 26529865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.